Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version 18 (2025-06-11) adds updates to Study Identification, Study Status, Study Description, Arms and Interventions, and Outcome Measures. This reflects revised or newly reported trial details and status.
    Difference
    0.2%
    Check dated 2025-11-03T12:34:26.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Key updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).
    Difference
    11%
    Check dated 2025-10-05T17:19:36.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-28T10:05:36.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Update: Revision changed from v3.0.1 to v3.0.2, a minor version upgrade. The 'Back to Top' element was removed, a small UI change with no impact on core content.
    Difference
    0.6%
    Check dated 2025-09-14T00:17:53.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T21:13:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    27%
    Check dated 2025-08-30T15:40:34.000Z thumbnail image

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.